Stratos Wealth Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $297K | Sell |
3,800
-305
| -7% | -$24.6K | 0.02% | 499 |
|
|
2026
Q1 | $356K | Buy |
4,105
+69
| +2% | +$6.61K | 0.02% | 450 |
|
|
2025
Q4 | $388K | Sell |
4,036
-1,180
| -23% | -$115K | 0.02% | 486 |
|
|
2025
Q3 | $497K | Sell |
5,216
-910
| -15% | -$83.7K | 0.02% | 464 |
|
|
2025
Q2 | $534K | Sell |
6,126
-729
| -11% | -$61.8K | 0.03% | 437 |
|
|
2025
Q1 | $616K | Buy |
6,855
+293
| +4% | +$26.2K | 0.03% | 396 |
|
|
2024
Q4 | $524K | Sell |
6,562
-5,844
| -47% | -$506K | 0.03% | 457 |
|
|
2024
Q3 | $1.12M | Buy |
12,406
+4,565
| +58% | +$384K | 0.05% | 331 |
|
|
2024
Q2 | $617K | Sell |
7,841
-2,614
| -25% | -$214K | 0.03% | 423 |
|
|
2024
Q1 | $911K | Sell |
10,455
-753
| -7% | -$64.3K | 0.05% | 346 |
|
|
2023
Q4 | $923K | Sell |
11,208
-2,019
| -15% | -$154K | 0.05% | 343 |
|
|
2023
Q3 | $1.04M | Buy |
13,227
+151
| +1% | +$12.6K | 0.07% | 294 |
|
|
2023
Q2 | $1.15M | Sell |
13,076
-1,248
| -9% | -$107K | 0.08% | 271 |
|
|
2023
Q1 | $1.15M | Buy |
14,324
+1,314
| +10% | +$107K | 0.09% | 254 |
|
|
2022
Q4 | $1.01M | Sell |
13,010
-3,063
| -19% | -$248K | 0.08% | 276 |
|
|
2022
Q3 | $1.3M | Sell |
16,073
-5,760
| -26% | -$518K | 0.14% | 201 |
|
|
2022
Q2 | $1.96M | Buy |
21,833
+359
| +2% | +$36.4K | 0.18% | 151 |
|
|
2022
Q1 | $2.38M | Buy |
21,474
+252
| +1% | +$26.6K | 0.19% | 137 |
|
|
2021
Q4 | $2.19M | Buy |
21,222
+1,184
| +6% | +$137K | 0.16% | 172 |
|
|
2021
Q3 | $2.51M | Buy |
20,038
+5,512
| +38% | +$713K | 0.21% | 129 |
|
|
2021
Q2 | $1.8M | Buy |
14,526
+3,417
| +31% | +$429K | 0.16% | 169 |
|
|
2021
Q1 | $1.31M | Buy |
11,109
+579
| +5% | +$67.9K | 0.14% | 181 |
|
|
2020
Q4 | $1.23M | Buy |
10,530
+5,017
| +91% | +$552K | 0.17% | 140 |
|
|
2020
Q3 | $573K | Sell |
5,513
-476
| -8% | -$47.8K | 0.14% | 164 |
|
|
2020
Q2 | $549K | Buy |
5,989
+1,766
| +42% | +$169K | 0.17% | 132 |
|
|
2020
Q1 | $381K | Buy |
4,223
+104
| +3% | +$11.1K | 0.27% | 91 |
|
|
2019
Q4 | $467K | Sell |
4,119
-728
| -15% | -$79.9K | 0.26% | 83 |
|
|
2019
Q3 | $527K | Sell |
4,847
-296
| -6% | -$30.9K | 0.2% | 108 |
|
|
2019
Q2 | $501K | Sell |
5,143
-68
| -1% | -$6.21K | 0.2% | 115 |
|
|
2019
Q1 | $475K | Buy |
5,211
+41
| +0.8% | +$3.67K | 0.26% | 105 |
|
|
2018
Q4 | $470K | Buy |
+5,170
| New | +$483K | 0.31% | 95 |
|
Other funds holding MDT
Stratos Wealth Advisors's MDT Position: Q2 2026 in Review
Stratos Wealth Advisors reduced its Medtronic (MDT) stake by 7.4% in Q2 2026, selling an estimated $24.6K and leaving 3,800 shares worth $297K. The position accounts for 0.02% of the portfolio, ranked #499.
Stratos Wealth Advisors first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.51M in Q3 2021. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Stratos Wealth Advisors held 3,800 shares of Medtronic worth $297K as of Q2 2026.
- Stratos Wealth Advisors sold 305 Medtronic shares in Q2 2026, an estimated $24.6K.
- Medtronic made up 0.02% of Stratos Wealth Advisors's portfolio in Q2 2026, its #499 holding.
- Stratos Wealth Advisors first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- Stratos Wealth Advisors's Medtronic position peaked at $2.51M in Q3 2021.
- 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.